Market Research Logo

Lebanon Pharmaceuticals and Healthcare Report Q4 2015

Lebanon Pharmaceuticals and Healthcare Report Q4 2015

BMI View: The Lebanese Health Ministry's pledge to invest in improving the condition of poorly equippedstate-owned hospitals across the country as well as increasing its coverage of patient bills at such hospitalsreaffirms our view that the government remains committed to achieving universal access to healthcare.

Improving access to healthcare will be a key factor for sustained growth in the pharmaceutical sector.

However, the on-going civil war in neighbouring Syria and the resulting economic and politicalimplications continue to add downward pressure on the market.

Risk/Reward Index

For Q415, Lebanon's Pharmaceutical Risk/Reward Index (RRI) score is calculated at 55.6 out of 100, higherthan last quarter's score of 50.8. The Country's score is beaten only by the UAE (61.8) and Saudi Arabia(59.3), ranking the country third in the Middle East and Africa matrix, up from eighth position last quarter.


BMI Industry View
SWOT
Political
Economic
Operational Risk
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Lebanon 2011-2019)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Lebanon 2011-2019)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Lebanon 2011-2019)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Lebanon 2011-2019)
Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Lebanon 2011-2019)
Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Lebanon 2011-2019)
Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Lebanon 2011-2019)
OTC Medicine Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Lebanon 2011-2019)
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Lebanon 2013-2019)
Table: Pharmaceutical Trade Data And Forecasts local currency (Lebanon 2013-2019)
Key Risks To BMI's Forecast Scenario
Macroeconomic Forecasts
Economic Analysis
Industry Risk Reward Ratings
Middle East and Africa Risk/Reward Index
Lebanon Risk/Reward Index
Rewards
Risks
Market Overview
Industry Trends And Developments
Epidemiology
Healthcare Sector
Healthcare Insurance
Medical Tourism
Regional Healthcare Collaboration
Clinical Trials
Regulatory Development
Regulatory Developments
Counterfeit Drugs
Public Sector Procurement
Intellectual Property Regime
Free Trade Agreements
Pricing Regime
Reimbursement Regime
Competitive Landscape
Pharmaceutical Sector
Pharmaceutical Sector Developments
Pharmaceutical Distribution
Retail Pharmacy Sector
Company Profile
Abbott Laboratories
Alfa Laboratories
Algorithm
Benta Pharmaceutical Industries
Chalhoub Pharmaceuticals
Codipha
GlaxoSmithKline
Johnson & Johnson
Merck & Co
Novartis
Pfizer
Pharmaline
Sanofi
Demographic Forecast
Lebanon Demographic Forecast
Table: Population Headline Indicators (Lebanon 1990-2025)
Table: Key Population Ratios (Lebanon 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Lebanon 1990-2025)
Table: Population By Age Group (Lebanon 1990-2025)
Table: Population By Age Group % (Lebanon 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators
Indicator Weightings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report